This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Pretoria. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Mervyn Beukes: Innovator in Tuberculosis Detection
Introduction
Mervyn Beukes is a notable inventor based in Pretoria, South Africa. He has made significant contributions to the field of medical diagnostics, particularly in the detection of tuberculosis. His innovative approach has the potential to improve the accuracy and efficiency of diagnosing this serious disease.
Latest Patents
Mervyn Beukes holds a patent for a method of detecting surrogate markers in a serum sample. This invention specifically relates to identifying active tuberculosis infections in individuals. The method utilizes a single chain variable fragment from a monoclonal immunoglobulin that is specific for mycolic acids of mycobacterial origin. By detecting surrogate markers, such as serum mycolic acid antigen and serum anti-mycolic acid antibodies, the method indicates whether an individual has an active tuberculosis infection. A preferred embodiment of this method employs a lateral flow assay format, which enhances its practicality in clinical settings. He has 1 patent to his name.
Career Highlights
Mervyn Beukes is affiliated with the University of Pretoria, where he contributes to research and development in medical diagnostics. His work focuses on innovative solutions that address public health challenges, particularly in the realm of infectious diseases.
Collaborations
Mervyn has collaborated with Jan Adrianus Verschoor, working together to advance their research efforts in tuberculosis detection and other related fields.
Conclusion
Mervyn Beukes is a dedicated inventor whose work in tuberculosis detection showcases the importance of innovation in healthcare. His contributions have the potential to significantly impact the diagnosis and treatment of this critical disease.